Dr. Thomas Cooper , MD
Dermatology • Wellesley, MA
230 Worcester St
Wellesley, MA 024815420
This profile restates public CMS/NPPES data; T-MedInfo gives no medical advice — consult a licensed professional, and call 911 for emergencies.
-
NPI assigned on June 28, 2005; this date does not establish years in practice.
-
Published CMS data list 1,480 Original Medicare Part B services in 2023.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2023. Published rows only; this is not a quality measure.
-
Published Part B service records, 2023:
- 17003 — Destruction of precancer skin growth, 2-14 growths: 659 service units.
- 99213 — Established patient outpatient office visit: 345 service units.
- 17000 — Destruction of precancer skin growth, 1 growth: 234 service units.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2023. Units differ by code; these are not visits or a measure of quality.
CPT® only copyright 2022 American Medical Association. All rights reserved. Service names are shortened from CPT Consumer Friendly Descriptors (CMS data, 2023). CPT notice
See all 8 records in the table · Guide: How to read Medicare Part B data
-
Published CMS data list 12 Medicare Part D prescriptions, including refills, in 2024.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Published rows only; this is not a quality measure.
-
Published Part D records, 2024:
- Ketoconazole — 12 prescription fills, including refills.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Drug names come from pharmacy claims. Listing a drug here is not an endorsement or a recommendation.
See the full table · Guide: How to read Medicare Part D prescriber data
-
Fewer Part D prescriptions than 95% of clinicians listed under Dermatology in Wellesley, MA (2024, 24 clinicians with data). Median for this group: 320. Middle half: 153 to 504.
Fewer Part D prescriptions than 95% of clinicians listed under Dermatology in Massachusetts (2024, 458 clinicians with data). Median for this group: 433. Middle half: 155 to 825.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024. Billing and prescribing volume is not a quality rating.
-
Medicare Part B services went from 3,084 in 2019 to 1,480 in 2023.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2019–2023.
Practice Location & Contact Primary Location
230 Worcester St
Wellesley, MA 024815420
Matched by practice address or phone in NPPES. A shared address or phone does not confirm that this clinician works there.
What Public CMS Data Show
Dermatology: NPPES taxonomy is a reported classification, not proof of board certification.
Medicare-allowed amount
About $81,680 in 2023
The total amount Medicare approved for these services in 2023. It includes what Medicare paid and what patients or their other insurance owed, such as the deductible and coinsurance.
It shows the total cost of this clinician's Original Medicare services under Medicare's fee rules.
What this does not show: Medicare-allowed amount
This is not the clinician's income. Part of it can go to a clinic or group practice, staff, equipment or drugs. It is not the price you will pay.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2023.
Paid by Medicare
About $56,372 in 2023
The part of the Medicare-allowed amount that Medicare itself paid in 2023, after patients' deductibles and coinsurance.
The gap between the allowed amount and this number is roughly what patients and their other insurance paid.
What this does not show: Paid by Medicare
This is not the clinician's income and not a measure of quality.
Source: CMS, Medicare Physician & Other Practitioners – by Provider and Service, 2023.
30-day fills
16 standardized 30-day fills in 2024
CMS converts prescriptions to 30-day supplies so they can be compared. A 90-day prescription counts as about three 30-day fills.
What this does not show: 30-day fills
It is not a count of patients and not a measure of quality.
Part D drug cost
$329 in 2024
The total cost of these prescriptions in 2024, paid by Medicare drug plans, patients and other payers together.
It shows the total spending on drugs this clinician prescribed, not what any one patient paid.
What this does not show: Part D drug cost
A higher cost often reflects the type of medicines a specialty uses. It is not your out-of-pocket cost and not a measure of quality.
Source: CMS, Medicare Part D Prescribers – by Provider and Drug, 2024.
Open Payments general payments, program year 2023
All general payments: $481.29 across 18 records.
By nature of payment
- Food and Beverage: $481.29 across 18 records.
Reporting-company totals (3 largest of 5)
- ABBVIE INC.: $179.74 across 6 records.
- Pfizer Inc.: $82.30 across 3 records.
- Incyte Corporation: $79.96 across 3 records.
A reported payment does not necessarily mean the financial relationship is improper and is not a measure of care quality. Clinicians can review and dispute these records.
Source: Calculated by T-MedInfo from CMS Open Payments general-payment records for program year 2023 (published June 30, 2026).
NPI first issued
2005
The year this clinician's National Provider Identifier (NPI) was issued. An NPI is a unique 10-digit ID that US health care providers use for billing.
What this does not show: NPI first issued
NPIs have been issued only since 2005, so this year is not necessarily when the clinician started practicing.
Source: CMS NPPES NPI Registry.
Medicare assignment not listed
CMS data do not show whether this clinician accepts Medicare assignment. This does not mean they do not accept Medicare. Ask the office.
Medicare assignment applies to Original Medicare. It does not tell you whether the clinician is in a Medicare Advantage plan's network, accepts other insurance, or is taking new patients.
Source: CMS Doctors and Clinicians; Medicare.gov, “Does your provider accept Medicare as full payment?”
No telehealth indicator
CMS shows this indicator only when recent Medicare claims include telehealth services. The clinician may still offer telehealth; ask the office.
Source: CMS, Telehealth Indicator on Medicare Care Compare (fact sheet, January 2023); CMS Doctors and Clinicians.
Compared with the same specialty in Wellesley and Massachusetts
Billing and prescribing volume is not a quality rating.
Medicare Part D prescriptions
Fewer Part D prescriptions than 95% of clinicians listed under Dermatology in Wellesley, MA (2024, 24 clinicians with data). Median for this group: 320. Middle half: 153 to 504.
Fewer Part D prescriptions than 95% of clinicians listed under Dermatology in Massachusetts (2024, 458 clinicians with data). Median for this group: 433. Middle half: 155 to 825.
Part D drug cost
A lower Part D drug cost than 95% of clinicians listed under Dermatology in Wellesley, MA (2024, 24 clinicians with data). Median for this group: $13,504. Middle half: $4,565 to $87,417.
A lower Part D drug cost than 95% of clinicians listed under Dermatology in Massachusetts (2024, 458 clinicians with data). Median for this group: $90,594. Middle half: $5,876 to $363,288.
Medicare Part B
Comparisons use 2024 data. The latest CMS data for Dr. Cooper are from 2023.
26 active clinicians are listed under Dermatology with a practice address in Wellesley, MA (627 in Massachusetts).
Addresses are self-reported to NPPES and may be out of date.
Telehealth indicator in Wellesley
0% of these 26 clinicians have the CMS telehealth indicator.
73.1% of these 26 clinicians are listed by CMS as accepting Medicare assignment.
CMS data by year
Changes may reflect reporting, coverage or privacy limits, not changes in care quality.
-
Medicare Part B services
Medicare Part B services decreased 52% from 3,084 in 2019 to 1,480 in 2023.
- 2019: 3,084
- 2020: 1,617
- 2021: 1,465
- 2022: 1,205
- 2023: 1,480
-
Medicare-allowed amount
Medicare-allowed amount decreased 18% from $99,616 in 2019 to $81,680 in 2023.
- 2019: $99,616
- 2020: $58,334
- 2021: $69,558
- 2022: $62,619
- 2023: $81,680
-
Paid by Medicare
Paid by Medicare decreased 16% from $67,134 in 2019 to $56,372 in 2023.
- 2019: $67,134
- 2020: $36,861
- 2021: $46,127
- 2022: $42,232
- 2023: $56,372
-
Medicare Part D prescriptions
Medicare Part D prescriptions decreased 97% from 387 in 2020 to 12 in 2024.
- 2020: 387
- 2021: 382
- 2022: 239
- 2023: 220
- 2024: 12
-
30-day fills
30-day fills decreased 96% from 435 in 2020 to 16 in 2024.
- 2020: 435
- 2021: 411
- 2022: 257
- 2023: 241
- 2024: 16
-
Part D drug cost
Part D drug cost decreased 99% from $24,043 in 2020 to $329 in 2024.
- 2020: $24,043
- 2021: $136,417
- 2022: $95,776
- 2023: $139,221
- 2024: $329
-
Industry payments (Open Payments)
Industry payments (Open Payments) went from $566.93 in 2019 to $481.29 in 2023.
- 2019: $566.93
- 2020: $99.58
- 2021: $73.90
- 2022: $189.80
- 2023: $481.29
Sources: CMS Medicare Physician & Other Practitioners (2023), CMS Medicare Part D Prescribers (2024), CMS Open Payments (2023), CMS Doctors and Clinicians, CMS NPPES NPI Registry. Specialty names follow the NUCC Health Care Provider Taxonomy.
Text: T-MedInfo · Report an error.
Pharma & Medical Device Financial Disclosures
Payments and other transfers of value that drug and medical device companies reported to CMS Open Payments
Program year 2023 (payments made January 1 – December 31, 2023): 18 records totaling $481.29.
| Manufacturer | Payment Nature | Product | Type | Amount ($) |
|---|---|---|---|---|
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
RINVOQ | General | $34.48 |
| Eli Lilly and Company |
Food and Beverage
In-kind items and services
|
TALTZ | General | $34.13 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
SKYRIZI | General | $34.00 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
SKYRIZI | General | $32.54 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
RINVOQ | General | $31.93 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
EUCRISA | General | $30.36 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
EUCRISA | General | $29.25 |
| Incyte Corporation |
Food and Beverage
Cash or cash equivalent
|
OPZELURA | General | $27.82 |
| Eli Lilly and Company |
Food and Beverage
In-kind items and services
|
TALTZ | General | $27.48 |
| Incyte Corporation |
Food and Beverage
Cash or cash equivalent
|
OPZELURA | General | $27.02 |
| Bristol Myers Squibb Company |
Food and Beverage
Cash or cash equivalent
|
— | General | $26.22 |
| Incyte Corporation |
Food and Beverage
Cash or cash equivalent
|
OPZELURA | General | $25.12 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
SKYRIZI | General | $23.57 |
| ABBVIE INC. |
Food and Beverage
In-kind items and services
|
SKYRIZI | General | $23.22 |
| Pfizer Inc. |
Food and Beverage
In-kind items and services
|
EUCRISA | General | $22.69 |
| Bristol Myers Squibb Company |
Food and Beverage
Cash or cash equivalent
|
Sotyktu | General | $18.33 |
| Bristol Myers Squibb Company |
Food and Beverage
Cash or cash equivalent
|
Sotyktu | General | $16.69 |
| Bristol Myers Squibb Company |
Food and Beverage
Cash or cash equivalent
|
Sotyktu | General | $16.44 |
Source: CMS Open Payments, program year 2023, released June 30, 2026.
Performed Procedures & Service Volume
CPT® is a registered trademark of the American Medical Association. CPT codes, descriptions and other data only are copyright 2016–2022 American Medical Association. All rights reserved. Applicable FARS/HHSARS apply. Descriptions of CPT codes are the AMA's CPT Consumer Friendly Descriptors as published by CMS in the Medicare Physician & Other Practitioners – by Provider and Service data, 2017–2023; they are plain-language summaries, not for clinical coding or documentation. HCPCS Level II codes and descriptions are from CMS. Fee schedules, relative value units, conversion factors and/or related components are not assigned by the AMA, are not part of CPT, and the AMA is not recommending their use. The AMA does not directly or indirectly practice medicine or dispense medical services. The AMA assumes no liability for data contained or not contained herein.
| HCPCS Code | Services | Patients | Submitted Charge | Medicare Allowed |
|---|---|---|---|---|
|
17003
Destruction of precancer skin growth, 2-14 growths
|
659 | 161 | $27.00 | $7.81 |
|
99213
Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more
|
345 | 283 | $265.04 | $99.66 |
|
17000
Destruction of precancer skin growth, 1 growth
|
234 | 195 | $206.00 | $69.06 |
|
17110
Destruction of skin growth, 1-14 growths
|
66 | 64 | $328.00 | $132.18 |
|
11102
Biopsy of related skin growth, first growth
|
64 | 58 | $294.00 | $114.77 |
|
99212
Established patient office or other outpatient visit with straightforward medical decision making, if using time, 10 minutes or more
|
55 | 50 | $167.20 | $61.75 |
|
99203
New patient office or other outpatient visit with low level of medical decision making, if using time, 30 minutes or more
|
45 | 45 | $346.00 | $123.47 |
|
99202
New patient office or other outpatient visit with straightforward medical decision making, if using time, 15 minutes or more
|
12 | 12 | $242.00 | $80.77 |
Source: CMS Part B by Provider and Service, 2023; services under 11 beneficiaries omitted by CMS. Privacy limits
Submitted charges are billed amounts, not a price quote for your visit.
Medicare Part D Prescribing Profile & Medications
Medicare Part D prescriptions filled, including refills, in 2024.
| Brand Name | Generic Name | Prescriptions | Day Supply | Total Cost | Patients |
|---|---|---|---|---|---|
| Ketoconazole | Ketoconazole | 12 | 480 | $329.31 | — |
Source: CMS Part D by Provider and Drug, 2024; rows below 11 claims omitted by CMS; volume isn’t quality. Privacy limits
Specialties & License Numbers Reported to NPPES
Self-certified to NPPES: 2020-11-24NUCC Taxonomy Code: 207N00000X
A dermatologist is trained to diagnose and treat pediatric and adult patients with benign and malignant disorders of the skin, mouth, external genitalia, hair and nails, as well as a number of sexually transmitted diseases. The dermatologist has had additional training and experience in the diagnosis and treatment of skin cancers, melanomas, moles and other tumors of the skin, the management of contact dermatitis and other allergic and nonallergic skin disorders, and in the recognition of the skin manifestations of systemic (including internal malignancy) and infectious diseases. Dermatologists have special training in dermatopathology and in the surgical techniques used in dermatology. They also have expertise in the management of cosmetic disorders of the skin such as hair loss and scars and the skin changes associated with aging.
Additional State Medicaid & Healthcare Payer Identifiers
Clinicians Sharing This Practice Address or Phone
Clinicians sharing this NPPES address, phone or fax; a shared contact does not mean they work together.
Nurse Practitioner - Adult Health
Certified Nurse Practitioner
Urology
Doctor of Medicine (M.D.)
Physician Assistant
Physician Assistant (Certified)
Dermatology - Procedural Dermatology
Doctor of Medicine (M.D.)
Career & Practice History Timeline
Changes recorded in monthly NPPES data files: addresses, names, credentials, specialties and NPI status
Registered at 230 WORCESTER ST, WELLESLEY, MA 024815420 (Tel: 7814315255)
Registered at 230 WORCESTER ST, WELLESLEY, MA 024815420 (Tel: 7814315255)
NPI status registered as active in NPPES database
Registered at 1 LYONS ST, DEDHAM, MA 020265599 (Tel: 7813291400)
Registered at PO BOX 9120, DEDHAM, MA 020279120 (Tel: 7813291400)
Recorded as THOMAS COOPER, M.D.
Dermatology (license number reported to NPPES: MA 55056)
First registered as active Individual Practitioner in NPPES Database.
NPI Administrative Meta
Other Dermatology Specialists in Wellesley
- Dr. Emily Wise, MD
- Dr. Caren Droesch, MD
- Dr. Rashel Goodkin, MD
- Dr. Uchenna Okereke, MD, MSC
- Dr. Flavia Fedeles, MD
- Dr. Pamela Weinfeld, MD
Mailing Address
230 Worcester St
Wellesley, MA 024815420
Phone: 7814315255